Soc. Generale Knock-Out OMXS30/ DE000SW7XHK2 /
10/05/2024 10:13:10 | Chg.- | Bid22:00:36 | Demandez à22:00:36 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.001EUR | - | - Bid taille: - |
- Ask la taille: - |
OMX Stockholm 30 Ind... | 2,611.409 - | 31/12/2078 | Put |
GlobeNewswire
13:00
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunol...
GlobeNewswire
13:00
Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
GlobeNewswire
13:00
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wedn...
GlobeNewswire
13:00
Troilus Announces Feasibility Study Results for the Gold-Copper Troilus Project: Outlines a Large Sc...
GlobeNewswire
13:00
ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabl...
GlobeNewswire
13:00
One in four US subscribers will sign up to a new streaming service to watch the Olympics
GlobeNewswire
13:00
MetaWorks' New Venture, Energy Works, Inc., to Revolutionize Plastic Waste Management with Cutting-E...
GlobeNewswire
13:00
Bitfarms Doubles Yguazu Power Capacity to 200 MW with Additional 100 MW of Hydropower in Paraguay
GlobeNewswire
13:00
Hotel Equities Selected to Manage First Hampton by Hilton-Branded Hotel in St. Thomas, U.S. Virgin I...
GlobeNewswire
13:00
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
GlobeNewswire
13:00
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI S...
GlobeNewswire
13:00
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pha...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page